Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients (Q35005490)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients |
scientific article |
Statements
1 reference
Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients (English)
1 reference
Hans-Jürgen Stellbrink
1 reference
Joseph Eron
1 reference
François Raffi
1 reference
Robin Wood
1 reference
Keikawus Arasteh
1 reference
Eugenio Teofilo
1 reference
Richard B Pollard
1 reference
Jane Yeo
1 reference
Judith Millard
1 reference
Mary Beth Wire
1 reference
Odin J Naderer
1 reference
1 January 2004
1 reference
1 reference
48
1 reference
1
1 reference
116-123
1 reference
Identifiers
1 reference
1 reference
1 reference